[Skip Header and Navigation] [Jump to Main Content]
Home

Crohn's & Colitis Focus Group

  • Home
  • Groups & Projects
  • Protocols
  • Publications
  • Photo Gallery
  • Useful Links

Group & Projects

Prof. Benjamin Geiger

Benny.Geiger@weizmann.ac.il3910

Prof. David Wallach

D.Wallach@weizmann.ac.il3941

Dr. Eran Elinav

eran.elinav@weizmann.ac.il4014

Dr. Guy Shakhar

Guy.Shakhar@weizmann.ac.il3633

Prof. Idit Shachar

Idit.Shachar@weizmann.ac.il4257

The progress in understanding the mechanisms of T-cell trafficking, migration and homing, as well as towards the development of mechanisms for the inactivation of these events have been translated into treatment strategies of autoimmune diseases. Our ongoing studies focus on the analysis of pathways that restrict homing of T cell homing, and thereby fine-tune the immune response at specific lymphoid and peripheral tissues. We characterized two pathways that limit T cell migration impairing of lymphocyte homing to peripheral lymph nodes resulting in attenuated progression of inflammation like in various models, including IBD. We now focus on key molecules involved in this homing regulation, in an attempt to develop reagents that will block their function. 

Dr. Ido Amit

ido.amit@weizmann.ac.il3338

Prof. Irit Sagi

Irit.Sagi@weizmann.ac.il2130

Prof. Michal Neeman

Michal.Neeman@weizmann.ac.il2487

Dr. Rotem Sorek

Rotem.Sorek@weizmann.ac.il6342

The Sorek laboratory studies the dynamics of phage attacks and phage resistance among bacteria that inhabit the human gut in Crohn/IBD and normal patients. The team is testing the hypothesis that part of the shift in the gut microbial population that is observed in IBD patients, is connected to bacteriophages that attack gut bacteria.

Prof. Steffen Jung

S.Jung@weizmann.ac.il2787

Efforts of the Jung laboratory focus on defining the origins and functions of intestinal mononuclear phagocytes, including monocytes, dendritic cells and macrophages, in steady state, as well as acute and chronic bowel disorders caused by pathogen challenge (Citrobacter rodentium), irritant exposure (DSS) or genetic predispositions (IL10 deficiency).

Prof. Yair Reisner

yair.reisner@weizmann.ac.il4023

Prof. Yechiel Shai

Yechiel.Shai@weizmann.ac.il2711

Prof. Yoram Groner

Yoram.Groner@weizmann.ac.il3972

Runx3 transcription factor is a key hematopoietic gene expression regulator. In the murine gastrointestinal tract (GIT) Runx3 is highly expressed in leukocytes but not in the GIT epithelium. Previously, we found that Runx3-/- mice spontaneously develop inflammatory bowel disease (IBD) and have shown that Runx3 is required for the development and function of dendritic cells (DC). Given that DC play crucial role in mucosal immunity we have generated DCRunx3-/- mice and demonstrated that these mice develop IBD with characteristics similar to those observed in Runx3-/- mice. We thus established DCRunx3-/- mice as an attractive and highly specific model recapitulating the hallmarks of human IBD underscoring the importance of Runx3 in DC-mediated GIT homeostasis. We currently use the DCRunx3-/- mouse model to elucidate the molecular mechanisms underlying IBD development due to lack of Runx3 in lamina propria DC.

Prof. Zelig Eshhar

Zelig.Eshhar@weizmann.ac.il3965

Malfunction of regulatory T cells (Treg's) is associated with IBD. The Eshhar group has developed means to generate antigen-specific Treg's and provided evidence that adoptive transfer of such genetically modified cells can cure acute colitis.  Ongoing research  focuses on studying the role of Treg's in IBD and on the design and application of redirected Treg's for the suppression of autoimmune chronic colitis and the treatment of ensuing colorectal tumors.

webmaster@weizmann.ac.il

Site Last Updated: 15.03.13

[Jump to Top] [Jump to Main Content]